EVO 2, an AI that could change everyt... - Fight Prostate Ca...

Fight Prostate Cancer

2,989 members1,365 posts

EVO 2, an AI that could change everything

Maxone73 profile image
2 Replies

Super powerful, open-source...dynamite especially if used together with AlphaFold...let me introduce you EVO 2

Evo 2 AI is transforming synthetic biology, enabling genome design and mutation prediction with unprecedented accuracy. Developed by Arc Institute, NVIDIA, and top universities, it processes up to one million nucleotides at once.

Unlike AlphaFold, which predicts protein structures, Evo 2 operates at the genetic level, designing entire bacterial-scale genomes and novel biological mechanisms. It achieved over 90% accuracy in identifying pathogenic BRCA1 mutations and is shaping breakthroughs in medicine, agriculture, and biotechnology.

Evo 2 is pushing synthetic biology beyond analysis into active genome creation, unlocking new possibilities in bioengineering.

Add this to AlphaFold and AlphaProteo, then sprinkle the tumor reversion platform created by KAIST in Korea...and you have a very nice cocktail!

prostatewarriors.com/2025/0...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
2 Replies
KocoPr profile image
KocoPr

a cocktail not to drink for us warriors but for researchers to get snockered correct. Will we be around for the hangover and bloody mary in the morning?

Maxone73 profile image
Maxone73 in reply toKocoPr

if this is the speed, yes

Not what you're looking for?

You may also like...

Is It Just me? Lu-177 seems not to be as affective as once touted, seems Hyper / Hypo progression occurs in guys with mutations?

is it just me? Lu-177 seems not to be as affective as once touted, seems hyper / hypo progression...
Shorehousejam profile image

Consider Genetic Testing in All Metastatic Prostate Cancers— Expert panel recommendations from MedPage Today - June 10, 2020

At last some definitive support for genetic testing for PCa patients. From the MedPage Today...
cujoe profile image

Arnab Basu, MD, on Breaking the Barriers to Genetic Counseling in Prostate Cancer - ASCO Reading Room - MedPage Today - 04.07.2021

Why are so few eligible patients currently being referred? Short interview on the...
cujoe profile image

Participation in Clinical trials... What inspires people to participate, and is there a specific time to do them?? Thoughts???...

Greetings FPC members, I have been in discussions with another forum member about a clinical...
NPfisherman profile image

Revisiting the ORIOLE trial--SBRT vs Observation--Key Take Home points for the Oligometastatic PCa patient

Hello FPC members, After exchanging messages with another member, I wanted to review again the...
NPfisherman profile image